Alder BioPharmaceuticals Appoints Wendy L. Yarno to its Board of Directors
Apr 04, 2017 12:00 pm UTC| Business
BOTHELL, Wash., April 04, 2017 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced the appointment of Wendy L. Yarno...
PTS Diagnostics Announces New FDA 510(k) Clearance for Extended HDL Range Lipid Panel Test Strips
Apr 04, 2017 12:00 pm UTC| Business
INDIANAPOLIS, April 04, 2017 -- PTS Diagnostics, the US-based manufacturer of point-of-care biometric testing devices, announced today that the US Food and Drug Administration (FDA) has cleared1 an expanded top range...
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
Apr 04, 2017 12:00 pm UTC| Business
CULVER CITY, Calif. and SAN DIEGO, April 04, 2017 -- NantKwest, Inc. (Nasdaq:NK) and Viracta Therapeutics, Inc. announced the initial closing of a Series B Preferred financing round of up to $18.4 million with...
Proofpoint to Report First Quarter 2017 Financial Results
Apr 04, 2017 12:00 pm UTC| Business
SUNNYVALE, Calif., April 04, 2017 -- Proofpoint, Inc. (NASDAQ:PFPT), a leading next-generation security and compliance company, today announced it will issue a press release reporting financial results for the first...
76% of Respondents See Ransomware as Significant Business Threat, Says Varonis ISMG Survey
Apr 04, 2017 12:00 pm UTC| Business
NEW YORK, April 04, 2017 -- Varonis Systems, Inc. (NASDAQ:VRNS), a leading provider of software solutions that protect data from insider threats and cyberattacks, today announced new research, undertaken by Information...
Apr 04, 2017 12:00 pm UTC| Business
MALVERN, Pa., April 04, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biotechnology company focused on defining new standards of care in medical and aesthetic dermatology, today announced that...
Apr 04, 2017 12:00 pm UTC| Business
WALTHAM, Mass., April 04, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today the closing of the licensing agreement with Endoceutics, Inc. for the U.S. commercial rights to IntrarosaTM (prasterone)....